-
Registry Participant Spotlight: Paducah Physiatric Partners
-
HHS Announces Pain Management Best Practices Inter-Agency Task Force
-
Activase (alteplase) 100mg by Genentech: Recall - Lack of Sterility Assurance
-
Look for Your September Issue of The Physiatrist
-
AAPM&R Collaborates with AMSSM for Sports Ultrasound Videos
-
Unexpired Lots of Oxytocin Compounded with Either Lactated Ringers or Lactated Ringers and Dextrose by PharMEDium - Recall - Sub-Potency
-
PharMEDium Services, LLC Issues Voluntary Nationwide Recall of all unexpired lots of Oxytocin Compounded with Either Lactated Ringers or Lactated Ringers and Dextrose Due to Sub-Potency
-
Spinal Cord Injury Awareness Month - September 2017
-
Pain Awareness Month - September 2017
-
Hospira Issues Voluntary Worldwide Recall For Lots of Hydromorphone HCl Injection, USP, CII, (2 mg/mL) 1mg/mL Vial, and Levophed® (Norepinephrine Bitartrate Injection, USP), 4 mg/4 mL (1 mg/mL) Vial, Due to a Lack of Sterility Assurance
-
Let’s Celebrate Women in Medicine Month
-
AAPM&R Members in the News: August 2017
-
August Coding Q&A
-
Annual Assembly Early-Bird Savings End August 30!
-
AAPM&R Submits Comments on the 2018 Proposed Updates to the Quality Payment Program
-
Bella Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of All Sterile Drug Products Due to Lack of Sterility Assurance
-
Postponed: August 22 Town Hall: Health Care Reform on the Hill
-
CMS Proposes Changes to the Comprehensive Care for Joint Replacement Model, cancellation of the mandatory Episode Payment Models and Cardiac Rehabilitation Incentive Payment Model
-
Lorazepam Oral Concentrate, USP 2mg/mL by Amneal Pharmaceuticals: Recall - Misprinted Dosing Droppers
-
Registry Participant Spotlight: East Idaho Sports, Spine and Rehab Center